| Ticker | ANAB |
|---|---|
| ISIN | US0327241065 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and...
El precio actual de AnaptysBio, Inc. (ANAB) es de 58,88 , con una variación del 14,84%.
AnaptysBio, Inc. opera en el sector Healthcare, industria Biotechnology.